Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01400
|
|||||
| Drug Name |
NB-506
|
|||||
| Synonyms |
J-107185; L-753000; N-[12-(beta-D-Glucopyranosyl)-1,11-dihydroxy-5,7-dioxo-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-6-yl]formamide; 6-(Formamido)-12-(beta-D-glucopyranosyl)-1,11-dihydroxy-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione
|
|||||
| Indication | Solid tumours [ICD11: 2D4Z] | Discontinued in Phase 2 | [1] | |||
| Formula |
C27H22N4O10
|
|||||
| Canonical SMILES |
C1=CC2=C(C(=C1)O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC=O)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C(=CC=C6)O
|
|||||
| InChI |
InChI=1S/C27H22N4O10/c32-7-13-22(36)23(37)24(38)27(41-13)30-20-10(4-2-6-12(20)35)15-17-16(25(39)31(26(17)40)28-8-33)14-9-3-1-5-11(34)18(9)29-19(14)21(15)30/h1-6,8,13,22-24,27,29,32,34-38H,7H2,(H,28,33)/t13-,22-,23+,24-,27-/m1/s1
|
|||||
| InChIKey |
WHTCLLAVOBBKHK-ISCYQWKGSA-N
|
|||||
| CAS Number |
CAS 151069-12-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 562.5 | Topological Polar Surface Area | 218 | ||
| Heavy Atom Count | 41 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 8 | Hydrogen Bond Acceptor Count | 10 | |||
| XLogP |
0.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:50883
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005106) | |||||
| 2 | Pharmacogenomic importance of ABCG2. Pharmacogenomics. 2008 Aug;9(8):1005-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.